Reference
KPV acetate
Status · October 2026
Under an interim HHS enforcement-discretion policy filed with the Federal Register on October 28, 2026, HHS has said it will not prioritize enforcement against State-licensed pharmacies, Federal facilities and licensed physicians that compound KPV (acetate) for a patient-specific prescription, for the routes below and under the policy’s other conditions. This is not FDA approval. Compounded drugs are not FDA-approved, and HHS can change or withdraw the policy.
Read the HHS policy (PDF)HHS Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances (PDF, hhs.gov)
- Covered form
- acetateOther forms are not covered.
- Covered routes
- Oral
- Topical
- Ingredients
- Single ingredient only. Blends aren’t covered.
- Needs
- A prescription written for you
- Note
- Oral forms are covered only when the compounder documents adequate oral bioavailability in humans (condition 8 of the policy).
- In Ondial
- KPV is saved as acetate, and only the covered routes above can be picked. Dose and strength are copied from your label as you see them; Ondial never suggests either.
Ask your prescriber
- What should I do if I miss a dose?
- Which side effects mean I should call you?
- How should I store it, and for how long?
- When should I stop taking it?
Ondial is a tracking tool, not medical advice. Not affiliated with HHS, the FDA or any pharmacy.